UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058829
Receipt number R000067264
Scientific Title Association between Acute Respiratory Acidosis and Hyperkalemia During Esophageal Cancer Surgery in the Prone Position: A Retrospective Observational Study
Date of disclosure of the study information 2025/08/19
Last modified on 2025/08/18 22:27:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Association between Acute Respiratory Acidosis and Hyperkalemia During Esophageal Cancer Surgery in the Prone Position: A Retrospective Observational Study

Acronym

PRO-K study

Scientific Title

Association between Acute Respiratory Acidosis and Hyperkalemia During Esophageal Cancer Surgery in the Prone Position: A Retrospective Observational Study

Scientific Title:Acronym

PRO-K study

Region

Japan


Condition

Condition

Esophageal cancer

Classification by specialty

Anesthesiology Intensive care medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Prone positioning has become an increasingly common approach for thoracoscopic esophageal cancer surgery to facilitate surgical exposure. It has been associated with better surgical outcomes and improved perioperative safety compared to the classical lateral decubitus position. However, it may significantly impact ventilation. Partial lung collapse and intrathoracic insufflation of carbon dioxide (CO2), commonly used in these procedures, may contribute to abrupt shifts in respiratory physiology and acid-base balance. Clinically, transient elevations in serum potassium levels associated with acute respiratory acidosis are often observed during these surgeries. While acidosis is generally known to affect potassium distribution, respiratory acidosis is typically considered to cause only mild increases in serum potassium compared to metabolic acidosis. However, recent clinical reports challenge this view in the setting of critical illness; for instance, Pathak and Nanda described cases of severe, refractory hyperkalemia in COVID-19 patients where acute respiratory acidosis was identified as a major contributing factor. Nevertheless, the combination of prone positioning, ventilatory compromise, and CO2 insufflation may alter the expected
physiological response. This study aims to investigate whether acute elevations in arterial carbon dioxide partial pressure (PaCO2) during esophageal cancer surgery in the prone position are associated with significant increases in serum potassium levels, and to explore the clinical implications of these changes. This research may contribute to establishing safer ventilation strategies and optimizing electrolyte management during these procedures.
```

Basic objectives2

Others

Basic objectives -Others

To identify risk factors for hyperkalemia during esophagectomy in the prone position using multivariate analysis.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The mean difference in serum potassium levels between the baseline (supine) and the intraoperative (prone) timepoints.

Key secondary outcomes

Factors Associated with Change in Serum Potassium (change in K+)
Correlation between the change in K+ and changes in physiological variables (e.g., PaCO2, lactate).
Multivariable analysis to identify independent factors associated with the magnitude of the change in K+.

Sensitivity Analysis of the Primary Outcome
Re-evaluation of the primary outcome after excluding cases with severe metabolic acidosis.

Exploratory and Clinical Analyses
Exploratory analysis of risk factors for clinically significant hyperkalemia (serum K+ > 5.0 mEq/L).
Subgroup analyses based on preoperative renal function and bronchial blocker usage.
Descriptive analysis of other acid-base parameters (e.g., HCO3-, BE).


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who underwent thoracoscopic esophagectomy (including robot-assisted surgery) in the prone position.

Key exclusion criteria

Patients undergoing chronic dialysis

Patients with severe electrolyte abnormalities (defined as a preoperative serum potassium level of 5.0 mEq/L or higher)

Patients who received intraoperative massive transfusion (defined as having received a transfusion for a blood loss of 2000 ml or more)

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Sakura
Middle name
Last name Okamoto

Organization

Aichi Medical University Hospital

Division name

Department of Anesthesiology

Zip code

4801195

Address

1-1 Karimatamata, Yazako, Nagakute, Aichi, Japan

TEL

0561-62-3311

Email

sokamotoanes@gmail.com


Public contact

Name of contact person

1st name Sakura
Middle name
Last name Okamoto

Organization

Aichi Medical University Hospital

Division name

Department of Anesthesiology

Zip code

4801195

Address

1-1 Karimatamata, Yazako, Nagakute, Aichi, Japan

TEL

0561-62-3311

Homepage URL


Email

sokamotoanes@gmail.com


Sponsor or person

Institute

Aichi Medical University

Institute

Department

Personal name



Funding Source

Organization

Aichi Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Aichi Medical University Ethics Committee

Address

1-1 Karimatamata, Yazako, Nagakute, Aichi, Japan

Tel

0561-62-3311

Email

sokamotoanes@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛知医科大学病院、愛知県がんセンター


Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

150

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2025 Year 07 Month 21 Day

Date of IRB

2025 Year 07 Month 22 Day

Anticipated trial start date

2025 Year 07 Month 22 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a two-center, retrospective observational study. The study will include adult patients who underwent thoracoscopic esophagectomy in the prone position at Aichi Medical University Hospital and Aichi Cancer Center between 2022 and 2024. Medical and anesthesia records will be retrospectively reviewed to evaluate the association between intraoperative acute respiratory acidosis and changes in serum potassium levels.
The primary outcome is the mean change in serum potassium level from the baseline (supine position) to the intraoperative period (prone position). Secondary outcomes include exploring physiological factors associated with the change in serum potassium (e.g., PaCO2), identifying risk factors for clinically significant hyperkalemia, and conducting subgroup analyses based on factors such as preoperative renal function.


Management information

Registered date

2025 Year 08 Month 18 Day

Last modified on

2025 Year 08 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067264